Australia markets closed
  • ALL ORDS

    7,735.80
    -3.50 (-0.05%)
     
  • AUD/USD

    0.7194
    -0.0019 (-0.27%)
     
  • ASX 200

    7,408.80
    -8.50 (-0.11%)
     
  • OIL

    85.38
    +1.56 (+1.86%)
     
  • GOLD

    1,816.60
    +0.10 (+0.01%)
     
  • BTC-AUD

    58,667.44
    -1,321.09 (-2.20%)
     
  • CMC Crypto 200

    1,012.74
    -12.99 (-1.27%)
     

Pharmaceutical Sterility Testing Global Market Research Report 2021 with Focus on Sterility Testing, Bioburden Testing, & Bacterial Endotoxin Testing - ResearchAndMarkets.com

·4-min read

DUBLIN, December 07, 2021--(BUSINESS WIRE)--The "Pharmaceutical Sterility Testing Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical sterility testing market is expected to grow from $1.01 billion in 2020 to $1.12 billion in 2021 at a compound annual growth rate (CAGR) of 10.9%. The market is expected to reach $1.69 billion in 2025 at a CAGR of 10.8%.

Major players in the pharmaceutical sterility testing market are Pacific Biolabs, STRERIS Corporation, Boston Analytical, Gibraltar Laboratories, Sartorius AG, SolviasAG, SGS AG, Toxikon, Inc., Pace Analytical Services LLC and Charles River Laboratories International Inc.

The pharmaceutical sterility testing market consists of sales of pharmaceutical sterility testing products and related services which are used to confirm that pharmaceutical products are free from the presence of viable microorganisms. Pharmaceutical sterility tests are procedures for checking the presence of microorganism in biological parenteral which are intended for human use.

Pharmaceutical sterility testing is an important process in pharmaceuticals, medical equipment, and drugs manufacturing to assess the effectiveness of a sterilization process and is carried out at all levels of manufacturing to reduce the risk of product contamination.

The pharmaceutical sterility testing market covered in this report is segmented by sample into sterile drugs, medical devices, biologics and therapeutics. It is also segmented by product type into instruments, kits and reagents, services; by type into in- house, outsourcing; by test type into sterility testing, bioburden testing, bacterial endotoxin testing and by end- user into compounding pharmacies, medical devices companies, pharmaceutical companies.

Companies in the pharmaceutical testing market are rising new pharmaceutical sterility testing products and services to enhance its product portfolio and increase its presence in the market. The companies are launching technologically superior outcomes and well-equipped services to utilize the growth potential of the rising pharmaceutical sterility market.

An Increase in the number of drug launches and rising investment in research and development (R&D) contributed to the growth of the pharmaceutical sterility testing market. Sterility is an important step in the manufacture of drugs to avoid product contamination and make the drugs free from any viable microorganism. According to a report published by Fierce Biotech shows that the top ten pharmaceutical companies invested over $82 billion in R&D in 2019.

Additionally, according to Pharma and Annual Review 2019 report, 1,273 new drugs were launched in the global market in 2019, a 6.2% increase from the previous year. Increased emphasis on quality and sterility coupled with increasing R&D activities in the pharmaceutical sector and rising production and launch of drug and medical devices is driving the market.

Key Topics Covered:

1. Executive Summary

2. Pharmaceutical Sterility Testing Market Characteristics

3. Pharmaceutical Sterility Testing Market Trends and Strategies

4. Impact Of COVID-19 On Pharmaceutical Sterility Testing

5. Pharmaceutical Sterility Testing Market Size and Growth

5.1. Global Pharmaceutical Sterility Testing Historic Market, 2015-2020, $ Billion

5.1.1. Drivers Of the Market

5.1.2. Restraints On the Market

5.2. Global Pharmaceutical Sterility Testing Forecast Market, 2020-2025F, 2030F, $ Billion

5.2.1. Drivers Of the Market

5.2.2. Restraints On the Market

6. Pharmaceutical Sterility Testing Market Segmentation

6.1. Global Pharmaceutical Sterility Testing Market, Segmentation by Sample, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Sterile Drugs

  • Medical Devices

  • Biologics and therapeutics

6.2. Global Pharmaceutical Sterility Testing Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Instruments

  • Kits and Reagents

  • Services

6.3. Global Pharmaceutical Sterility Testing Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • In- house

  • Outsourcing

6.4. Global Pharmaceutical Sterility Testing Market, Segmentation by Test Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Sterility Testing

  • Bioburden Testing

  • Bacterial Endotoxin Testing

6.5. Global Pharmaceutical Sterility Testing Market, Segmentation by End- User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Compounding Pharmacies

  • Medical Devices Companies

  • Pharmaceutical Companies

7. Pharmaceutical Sterility Testing Market Regional and Country Analysis

7.1. Global Pharmaceutical Sterility Testing Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7.2. Global Pharmaceutical Sterility Testing Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

  • Pacific Biolabs

  • STRERIS Corporation

  • Boston Analytical

  • Gibraltar Laboratories

  • Sartorius AG

  • Solvias AG

  • SGS AG

  • Toxikon Inc.

  • Pace Analytical Services LLC

  • Charles River Laboratories International Inc

  • Nelson Laboratories Inc

  • Rapid Micro Biosystems Inc.

  • BioMerieux

  • Merck KGaA

  • Wuxi AppTec

  • Sotera Health LLC

  • Dynalabs

  • Infinity

For more information about this report visit https://www.researchandmarkets.com/r/v3is1f

View source version on businesswire.com: https://www.businesswire.com/news/home/20211207006012/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting